Skip to main content
Top
Published in: Heart and Vessels 1/2012

01-01-2012 | Original Article

Differentiation profile of peripheral blood-derived vascular progenitor cell predicts intimal hyperplasia after coronary stenting

Authors: Chao-Hung Wang, I-Chang Hsieh, Wen-Jin Cherng, Chun-Chi Chen, Tao-Hsin Tung, Ju-Fang Lee, Shing-Jong Lin, Po-Nan Wang

Published in: Heart and Vessels | Issue 1/2012

Login to get access

Abstract

In-stent restenosis is largely due to intimal hyperplasia (IH). The number of vascular progenitor cells (VPCs) mobilized at the acute phase after stenting is associated with IH. This study sought to determine whether the differentiation profile of VPC predicts the development of IH. Peripheral blood was collected in 58 patients after bare-metal stenting to culture VPCs. Intravascular ultrasound was performed to estimate the area of IH 6 months after stenting. VPC differentiation was determined using flow cytometry. VE-cadherin (VE-Cad) and α-smooth muscle actin (α-SMA) were used to identify endothelial and smooth muscle cell lineages, respectively. After culturing, VPCs differentiated into four different phenotypes (α-SMAVE-Cad+, α-SMA+VE-cadhigh, α-SMA+VE-cadlow, and α-SMA+VE-Cad). IH was correlated with gender (P = 0.04), smoking status (P = 0.04), reference diameter (P = 0.03), minimal lumen diameter (P = 0.03), stent area (P < 0.0001), and parameters in the VPC differentiation profile (P < 0.05). Multivariate analysis controlling for stent area, smoking status, and gender revealed that IH was positively and independently associated with the number of differentiated α-SMA+VE-Cad low/− VPCs (P < 0.0001), and the ratio of α-SMA+VE-Cad low/− VPCs to α-SMAVE-Cad+ VPCs (P = 0.001). These parameters in the VPC differentiation profile independently predicted the IH and provided additive information to traditional risk factors. In conclusion, the profile of VPC differentiation predicts the severity of post-stent IH and may be a potential tool in the future for clinicians to identify patients at risk of post-stent restenosis.
Literature
1.
go back to reference Lowe HC, Oesterle SN, Khachigian LM (2002) Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 39:183–193PubMedCrossRef Lowe HC, Oesterle SN, Khachigian LM (2002) Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 39:183–193PubMedCrossRef
2.
go back to reference Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R (2007) Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27:1500–1510PubMedCrossRef Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R (2007) Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27:1500–1510PubMedCrossRef
3.
go back to reference Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, Xu Q (2004) Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 113:1258–1265PubMed Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, Xu Q (2004) Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 113:1258–1265PubMed
4.
go back to reference Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R (2002) Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8:403–409PubMedCrossRef Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R (2002) Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8:403–409PubMedCrossRef
5.
go back to reference Wang CH, Anderson N, Li SH, Szmitko PE, Cherng WJ, Fedak PW, Fazel S, Li RK, Yau TM, Weisel RD, Stanford WL, Verma S (2006) Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate. Circ Res 99:617–625PubMedCrossRef Wang CH, Anderson N, Li SH, Szmitko PE, Cherng WJ, Fedak PW, Fazel S, Li RK, Yau TM, Weisel RD, Stanford WL, Verma S (2006) Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate. Circ Res 99:617–625PubMedCrossRef
6.
go back to reference Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R (2002) Morphological predictors of restenosis after coronary stenting in humans. Circulation 105:2974–2980PubMedCrossRef Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R (2002) Morphological predictors of restenosis after coronary stenting in humans. Circulation 105:2974–2980PubMedCrossRef
7.
go back to reference Fukuda D, Shimada K, Tanaka A, Kawarabayashi T, Yoshiyama M, Yoshikawa J (2004) Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol 43:18–23PubMedCrossRef Fukuda D, Shimada K, Tanaka A, Kawarabayashi T, Yoshiyama M, Yoshikawa J (2004) Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol 43:18–23PubMedCrossRef
8.
go back to reference Fukuda D, Sata M, Tanaka K, Nagai R (2005) Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation 111:926–931PubMedCrossRef Fukuda D, Sata M, Tanaka K, Nagai R (2005) Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation 111:926–931PubMedCrossRef
9.
go back to reference Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967PubMedCrossRef Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967PubMedCrossRef
10.
go back to reference Deb A, Skelding KA, Wang S, Reeder M, Simper D, Caplice NM (2004) Integrin profile and in vivo homing of human smooth muscle progenitor cells. Circulation 110:2673–2677PubMedCrossRef Deb A, Skelding KA, Wang S, Reeder M, Simper D, Caplice NM (2004) Integrin profile and in vivo homing of human smooth muscle progenitor cells. Circulation 110:2673–2677PubMedCrossRef
11.
go back to reference Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:E1–E7PubMedCrossRef Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:E1–E7PubMedCrossRef
12.
go back to reference Egan CG, Caporali F, Capecchi PL, Lazzerini PE, Pasini FL, Sorrentino V (2010) Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients. Heart Vessels. doi:10.1007/s00380-010-0053-9 Egan CG, Caporali F, Capecchi PL, Lazzerini PE, Pasini FL, Sorrentino V (2010) Levels of circulating CXCR4-positive cells are decreased and negatively correlated with risk factors in cardiac transplant recipients. Heart Vessels. doi:10.​1007/​s00380-010-0053-9
13.
go back to reference Chen MC, Chen CJ, Yang CH, Liu WH, Fang CY, Hsieh YK, Chang HW (2008) Relationship of the percentage of circulating endothelial progenitor cell to the severity of coronary artery disease. Heart Vessels 23:47–52PubMedCrossRef Chen MC, Chen CJ, Yang CH, Liu WH, Fang CY, Hsieh YK, Chang HW (2008) Relationship of the percentage of circulating endothelial progenitor cell to the severity of coronary artery disease. Heart Vessels 23:47–52PubMedCrossRef
14.
go back to reference Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593–600PubMedCrossRef Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593–600PubMedCrossRef
15.
go back to reference George J, Herz I, Goldstein E, Abashidze S, Deutch V, Finkelstein A, Michowitz Y, Miller H, Keren G (2003) Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol 23:e57–e60PubMedCrossRef George J, Herz I, Goldstein E, Abashidze S, Deutch V, Finkelstein A, Michowitz Y, Miller H, Keren G (2003) Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol 23:e57–e60PubMedCrossRef
16.
go back to reference Wang CH, Verma S, Hsieh IC, Hung A, Cheng TT, Wang SY, Liu YC, Stanford WL, Weisel RD, Li RK, Cherng WJ (2007) Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 27:540–547PubMedCrossRef Wang CH, Verma S, Hsieh IC, Hung A, Cheng TT, Wang SY, Liu YC, Stanford WL, Weisel RD, Li RK, Cherng WJ (2007) Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 27:540–547PubMedCrossRef
17.
go back to reference Wang CH, Ciliberti N, Li SH, Szmitko PE, Weisel RD, Fedak PW, Al-Omran M, Cherng WJ, Li RK, Stanford WL, Verma S (2004) Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation 109:1392–1400PubMedCrossRef Wang CH, Ciliberti N, Li SH, Szmitko PE, Weisel RD, Fedak PW, Al-Omran M, Cherng WJ, Li RK, Stanford WL, Verma S (2004) Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation 109:1392–1400PubMedCrossRef
18.
go back to reference Inoue T, Sata M, Hikichi Y, Sohma R, Fukuda D, Uchida T, Shimizu M, Komoda H, Node K (2007) Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis. Circulation 115:553–561PubMedCrossRef Inoue T, Sata M, Hikichi Y, Sohma R, Fukuda D, Uchida T, Shimizu M, Komoda H, Node K (2007) Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis. Circulation 115:553–561PubMedCrossRef
19.
go back to reference Wang CH, Cherng WJ, Yang NI, Kuo LT, Hsu CM, Yeh HI, Lan YJ, Yeh CH, Stanford WL (2008) Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscler Thromb Vasc Biol 28:54–60PubMedCrossRef Wang CH, Cherng WJ, Yang NI, Kuo LT, Hsu CM, Yeh HI, Lan YJ, Yeh CH, Stanford WL (2008) Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscler Thromb Vasc Biol 28:54–60PubMedCrossRef
20.
go back to reference Verma S, Buchanan MR, Anderson TJ (2003) Endothelial function testing as a biomarker of vascular disease. Circulation 108:2054–2059PubMedCrossRef Verma S, Buchanan MR, Anderson TJ (2003) Endothelial function testing as a biomarker of vascular disease. Circulation 108:2054–2059PubMedCrossRef
21.
go back to reference Zhang LN, Wilson DW, da Cunha V, Sullivan ME, Vergona R, Rutledge JC, Wang YX (2006) Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation. Arterioscler Thromb Vasc Biol 26:765–772PubMedCrossRef Zhang LN, Wilson DW, da Cunha V, Sullivan ME, Vergona R, Rutledge JC, Wang YX (2006) Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation. Arterioscler Thromb Vasc Biol 26:765–772PubMedCrossRef
22.
go back to reference Wang CH, Ting MK, Verma S, Kuo LT, Yang NI, Hsieh IC, Wang SY, Hung A, Cherng WJ (2006) Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus. Am Heart J 152:1051.e1–1051.e8 Wang CH, Ting MK, Verma S, Kuo LT, Yang NI, Hsieh IC, Wang SY, Hung A, Cherng WJ (2006) Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus. Am Heart J 152:1051.e1–1051.e8
23.
go back to reference Moreno PR, Bernardi VH, López-Cuéllar J, Newell JB, McMellon C, Gold HK, Palacios IF, Fuster V, Fallon JT (1996) Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation 94:3098–3102PubMed Moreno PR, Bernardi VH, López-Cuéllar J, Newell JB, McMellon C, Gold HK, Palacios IF, Fuster V, Fallon JT (1996) Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation 94:3098–3102PubMed
24.
go back to reference Egashira K, Zhao Q, Kataoka C, Ohtani K, Usui M, Charo IF, Nishida K, Inoue S, Katoh M, Ichiki T, Takeshita A (2002) Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ Res 90:1167–1172PubMedCrossRef Egashira K, Zhao Q, Kataoka C, Ohtani K, Usui M, Charo IF, Nishida K, Inoue S, Katoh M, Ichiki T, Takeshita A (2002) Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ Res 90:1167–1172PubMedCrossRef
25.
go back to reference Caplice NM, Bunch TJ, Stalboerger PG, Wang S, Simper D, Miller DV, Russell SJ, Litzow MR, Edwards WD (2003) Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci USA 100:4754–4759PubMedCrossRef Caplice NM, Bunch TJ, Stalboerger PG, Wang S, Simper D, Miller DV, Russell SJ, Litzow MR, Edwards WD (2003) Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci USA 100:4754–4759PubMedCrossRef
26.
go back to reference Zohlnhöfer D, Klein CA, Richter T, Brandl R, Murr A, Nührenberg T, Schömig A, Baeuerle PA, Neumann FJ (2001) Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: detection of FK506-binding protein 12 upregulation. Circulation 103:1396–1402PubMed Zohlnhöfer D, Klein CA, Richter T, Brandl R, Murr A, Nührenberg T, Schömig A, Baeuerle PA, Neumann FJ (2001) Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: detection of FK506-binding protein 12 upregulation. Circulation 103:1396–1402PubMed
27.
go back to reference Zoll J, Fontaine V, Gourdy P, Barateau V, Vilar J, Leroyer A, Lopes-Kam I, Mallat Z, Arnal JF, Henry P, Tobelem G, Tedgui A (2008) Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition. Cardiovasc Res 77:471–480PubMedCrossRef Zoll J, Fontaine V, Gourdy P, Barateau V, Vilar J, Leroyer A, Lopes-Kam I, Mallat Z, Arnal JF, Henry P, Tobelem G, Tedgui A (2008) Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition. Cardiovasc Res 77:471–480PubMedCrossRef
Metadata
Title
Differentiation profile of peripheral blood-derived vascular progenitor cell predicts intimal hyperplasia after coronary stenting
Authors
Chao-Hung Wang
I-Chang Hsieh
Wen-Jin Cherng
Chun-Chi Chen
Tao-Hsin Tung
Ju-Fang Lee
Shing-Jong Lin
Po-Nan Wang
Publication date
01-01-2012
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 1/2012
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-011-0118-4

Other articles of this Issue 1/2012

Heart and Vessels 1/2012 Go to the issue